Aberdeen Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Aberdeen Group’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,991	Closed	-$296K	–	985
2023 Q4	$296K	Buy	+25,991	New	+$204K	﹤0.01%	913

Aberdeen Group's HARP Position: Q1 2024 in Review

Aberdeen Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 25,991 shares — an estimated $296K sold.

Aberdeen Group first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $296K in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Aberdeen Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Aberdeen Group sold 25,991 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $296K.
Aberdeen Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Aberdeen Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $296K in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.